Want to join the conversation?
David Steinberg of Jefferies asks whether there is any disruption in the market from the Valeant-Walgreens deal in the ophthalmic area. CEO Raj Rai said $AKRX has not seen any disruption in its ophthalmic products. He said his understanding is that Valeant is trying to sell their branded products as generics with the same kind of pricing.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.